biotech industry

Biotechnology

Presented By

Dheeraj

Indian Biotechnology Sector

§ The Biotechnology industry in India to reach $11.6 billion by 2017-Global Industry Analysis.

§ The opportunities for investors in Biotech industry are manifold.

§ In 2010-11 the Indian Biotech industry registered 21.5% growth, touching $4 billion mark clocking Rs 18,399.34 Cr.

§ The Biopharma segment continues to dominate biotech industry with 61.77% share in the overall revenue.

₰ In Asia Pacific market, India occupies 28.66% market share.

₰ India is in 12th rank in the world in biotechnology and 3rd largest in Asia-Pacific after Japan and Korea.

₰ The Sector employees approximately 20,000 scientists and over 352 companies drive it towards further growth.

₰ Karnataka is the Biotech Capital of India

Karnataka-India’s Biotech Hub

₴ The Biotech capital of India.₴ 60% of biotech companies are

having base in Bangalore.₴ 50% of the total revenues in

national biotechnology sector.₴ Growth in industrial output of

Karnataka’s biotech companies CAGR 11% per annum.

₴ Extensive Intellectual Capital– 12 Biotechnology finishing

schools under millennium biotech policy II

– 103 R&D Centers

• Extensive Intellectual Capital– Sector focused SEZs-Mysore,

Mangalore, Hubli-Dharward, Belgaum, Shimoga, Gulbarga,Kolar & Mandya.

– 86 acre Bitochnology park-“Bangalore Helix” with 52 acre Alexandria Knowledge Park in Bangalore.

• Pro Industry policy-State Millennium Biotech Policy II 2010, State Industrial Policy 2009-14– K-Bio Venture capital fund of

US$ 10.4 million with 26% stake holding by GoK

The Indian Biotechnology sector can be divided into the segments of biopharmaceuticals, bioservices, bioagriculture, bioindustrial and bioinformatics.

Nearly 40 percent of the biotech companies operate in the biopharma sector, followed by the bioservices (21 percent), bioagri (19 percent), bioinformatics (14 percent) and lastly the bioindustrial sector (5 percent).

Divisions

Biopharmaceuticals

• This constitutes the largest segment of the Indian biotech industry both in terms of domestic and export revenues.

• About 70 percent of the domestic biotech industry comprises of the Biopharma sector.

• Of the total 325biotechnology companies in India, more than 40 percent are in the biopharma sector.

• Vaccines, therapeutics and diagnostics fall into this category.

Bioservices

• The Bioservices market is the second largest sector of the Indian Biotechnology Industry.

• The market’s growth can be attributed to the fact that India has become a popular destination for clinical trial, contract research and manufacturing activities.

Agricultural Biotechnology

• This segment can be segmented into Hybrid seeds and transgenic crops, Biopesticides and Biofertilizers.

• Genetically modified cotton or commonly known as Bt cotton constitute approximately 77 percent of the revenue of this sector whereas Biopesticides and Biofertilizers together account only for 23 percent of the revenues by agricultural biotechnology.

Bioinformatics / BioIT

• This sector deals with the creation and maintenance of extensive electronic databases on various biological systems and is probably the smallest part of the current domestic biotechnology industry.

• However, India is known for its strong IT base and it is due to this that India is sure to become a leading destination for work in the bioinformatics arena.

Bioindustrial

• This industry predominantly consists of enzyme manufacturing and marketing companies.

• These enzymes are used in industries such as detergents, textiles, food, leather, paper and pharmaceuticals. This generates 6 percent of the revenues of the biotechnology industry.

List of Top Biotech 20 Companies Serum Institute of India Biocon Panacea Biotec Rasi Seeds Nuziveedu Seeds Novo Nordisk India Venkateshwara Hatcheries Indian Immunologicals Mahyco Monsanto Biotech GlaxoSmithKline Pharma Aventis Pharma Shantha Biotechnics Eli Lilly and Company(India) Mahyco Seeds Bharat Serums and Vaccines Novozymes South Asia Invert India Bharat Biotech International Ankur Seeds Advanced Enzyme Technologies

Serum Institute of India

Vaccine King

With a record sales of Rs 950.95 crore in 2010-11,

Serum Institute of India continues to be a leader in the vaccines market.

Business: Manufacturing and marketing of vaccines

and immuno-biologicals

CEO: Dr C S Poonawalla (CMD)

Biotech Revenue: Rs 950.95 crore

Start-up Year: 1966

Address: 212/2, Hadapsar, Off Soli Poonawalla Road,

Pune- 411 028

Biocon

Collective Expertise

Biocon's integrated business approach coupled with its collective expertise has enabled it to establish a

significant presence in the global

biopharmaceutical market.

Business: Biopharmaceuticals and industrial enzymes

CEO: Kiran Mazumdar Shaw

Biotech Revenue: Rs 823 crore

Start-up Year: 1978

Address: 20th KM Hosur Road, Electronic City, Bangalore –

560100

Panacea Biotec

Product Innovation

Panacea Biotec has added new drugs to its product basket like Siropan, Lower A,

Myelogen Forte, Inrica, TOFF Expectorant, Toff DC,

Upright SP and Trepro.

Business: Manufacturer of pharmaceuticals and biopharmaceuticals

CEO: Soshil Kumar Jain (MD)


Start-up Year: 1984

Address: B-1 Extn/G-3, Mohan Co-operative Industrial Estate, Mathura Road, New

Delhi – 110 044

Rasi Seeds

Bt Cotton Maker

Rasi Seeds accounted for 35 percent of the total Bt cotton

seeds sold in India in the year 2011.

Business: Producing and marketing

agri-biotechnology products

CEO: M Ramasami (MD)


Start-up Year: 1973

Address: 273, Kamarajanar Road, Attur, Salem - 636 102,

Tamil Nadu

Nuziveedu Seeds

Transgene Developer

Nuziveedu Seeds is working on its own indigenous transgene to combat bollworms and these technologies are expected to

be commercialized soon.

Business: Manufacturer of hybrid cotton seeds

CEO: M Prabhakar Rao


Start-up Year: 1973

Address: 7C, Surya Towers, 105 SP Road, Secunderabad – 500

003

Novo Nordisk India

Insulin Leader

Novo Nordisk India enjoys a lion's share in the Indian insulin market.

Novo Nordisk India

CEO: Melvin Oscar D'Souza (MD)


Business: Diabetes care products, human growth hormone and

haemostasis management.

Start-up Year: 1990

Address: 8th Floor, Raheja Towers, East Wing, 26/27, MG Road,

Bangalore- 560 001

Venkateshwara Hatcheries

Poultry Passion

Venkateshwara Hatcheries dominates the Indian poultry vaccines market

with a share of over 60 percent.

Venkateshwara Hatcheries

Business: Engaged in R&D, production and export of vaccines

and diagnostics kits

CEO: Anuradha Desai (Chairperson)


Start-up Year: 1971

Address: Venkateshwara House, SN 114/A/2,

Pune - Sinhgad Road,Pune - 411030

Indian Immunologicals

Animal Health Specialist

Indian Immunologicals Ltd (IIL) has bagged the distinction of being the largest exporter of veterinary biological in Asia.

Indian Immunologicals Ltd (IIL)

Business: Manufacturer of animal and human biological

CEO: KV Balasubramaniam


Start-up Year: 1983

Address: Road No.44, Jubilee Hills, Hyderabad - 500 033

Mahyco Monsanto Biotech

The Technologist

Mahyco Monsanto Biotech (India), a 50:50 joint venture with Mahyco and

Monsanto Holdings Pvt Ltd (MHPL), was created to bring the benefits of

Bollgard cotton technology to farmers in India.

Mahyco Monsanto Biotech (India)

Business: Marketing of Bt technology in India

CEO: Dr MK Sharma (MD)


Start-up Year: 1998

Address: Ahura Centre, 5th Floor, 96, Mahakali Caves Road, Andheri (East),

Mumbai - 400 093

GlaxoSmithKline Pharma

Novel Concepts

With growing competition from the local low-priced products, GSK has initiated novel concepts to bring awareness on the use of

vaccines in the country.

GlaxoSmithkline Pharmaceuticals

Business: Engaged in the sale of vaccines

CEO: Dr Hasit B Joshipura (MD)


Start-up Year: 2001

Address: GSK House, Dr Annie Besant Road, Worli, Mumbai - 400030

Aventis Pharma

Anti-rabies Vaccine Leader

Aventis Pharma leads the anti-rabies vaccine market in India, having a

market share of 60 percent.

Aventis Pharma

Business: Marketing of biotechnology products

CEO: Dr Shailesh Ayyangar (MD)


Address: Aventis House, 54/A, Sir Mathuradas Vasanji Road, Andheri

(East), Mumbai - 400 093

Shantha Biotechnics

The Trend Setter

As the first Indian company to launch an r-DNA vaccine in 1997, Shantha heralded

a new beginning for biotechnology in India.

Shantha Biotechnics

Business: Research, development, manufacture and marketing of

biotechnology-based human health care products

CEO: KI Varaprasad Reddy


Start-up Year: 1993

Address: Serene Chambers, 3rd Floor, Banjara Hills, Road No. 7,

Hyderabad - 500 034

Eli Lilly and Company(India)

TB Fighter

Eli Lilly India has committed $50 million to fight Multi-Drug

Resistant Tuberculosis (MDR-TB).

Eli Lilly & Company (India)

Business: Marketing of pharmaceutical products

CEO: Sandeep Gupta (MD)


Start-up Year: 1993

Address: Plot No. 92, Sector 32, Institutional Area, Gurgaon - 122

001

Mahyco Seeds

Bt Cotton Pioneer

Established in 1964, Mahyco is a pioneer and leader in the Indian

seed industry.

Maharashtra Hybrid Seed Company Ltd

Business: Diagnostics solutions for GM crop testing

CEO: BR Barwale (Chairman)


Start-up Year: 1964

Address: PO Box 76, Jalna - Aurangabad Road, Dawalwadi,

Dist.- Jalna,

Maharashtra – 431203

Bharat Serums and Vaccines

Recombinant Therapeutics Player

Bharat Serums and Vaccines has been focusing on developing new

generation recombinant therapeutics that replace the traditional plasma products

Bharat Serums and Vaccines

Business: Manufacturing and marketing of biological products

CEO: Bharat Daftary (CMD)


Start-up Year: 1971

Address: 16th Floor, Hoechst House, Nariman Point, Mumbai - 400 021

Novozymes South Asia

Enzymatic Endeavors

Novozymes produces and sells more than 600 enzyme products in 130

different countries, the largest geographical markets being Europe,

North America and Asia.

Novozymes South Asia

Business: Industrial enzymes

CEO: GS Krishnan


Start-up Year: 2000

Address: #16, 7th Floor, Innovator, International Technology Park,

Whitefield Road, Bangalore - 560 066

Invert India

The Veterinarian

Intervet India is one of the largest MNCs in India dedicated to

animal health. It offers a range of products consisting of

biological, therapeutics and productive hormones.

Intervet India

Business: R&D and manufacturing of veterinary biological

CEO: Dr Lino Componovo (MD)


Start-up Year: 1997

Address: Intervet House, 33, Pune-Nagar Road, (Behind Eden Gardens), Pune - 411 014

Bharat Biotech International

Healthcare Specialist

Bharat Biotech was established in 1996 with the objective of manufacturing unique vaccines and biotherapeutics.

Bharat Biotech International

Business: Manufacturer of human vaccines and biopharmaceuticals

CEO: Dr Krishna M Ella


Start-up Year: 1996

New initiatives: Manufacture of human rabies vaccines, formulation of

various vaccines and biopharmaceuticals. Address: Road

No. 65 Jubilee Hills, Hyderabad

Ankur Seeds

Agribiotech Player

Ankur Seeds boasts of having over 115 hybrids in various crops. It

also has a large collection of proprietary germplasm with

novel traits of all crops.

Ankur Seeds

Business: Engaged in research, processing and developing

hybrid and Bt seeds

CEO: MG Shembekar (MD)


Start-up Year: 1976

Address: 27, New Cotton Market Layout, Nagpur - 440 018

Advanced Enzyme Technologies

The Catalyst

Advanced Enzyme Technologies produces enzymes and probiotics worth over $20

million annually and it is the largest manufacturer of serratiopeptidase.

Advanced Enzyme Technologies

Business: R&D, manufacturing and marketing of enzymes for different

industries

CEO: Chandrakant L Rathi (MD)


Start-up Year: 1958

Address: 5th Floor 'A' Wing Sun Magnetica, Galaxy Accolade, Next to LIC Building,

Service Road, Louis Wadi, Near Teen Hath Naka,Thane-(w)400604

Market Forecast

• According to the “India in Business”, Ministry of External Affairs, Govt of India the forecast for 2015 is that the Indian biotech industry would have an annual revenues in excess of US$13 billion

• According to Global Industry Analysis-The Biotechnology industry in India to reach $11.6 billion by 2017

Favorable Climate

• Indian Copyright Act, 1957• The Patent Act, 1970• Indian Patents and Design Act, 1972• The Trademarks Act, 1999• Biotechnology Patent Facilitating

Cell (BPFC)• Foundation of Biotechnology

Awareness and Education (FBAE)• National Research Development

Corporation (NRDC)

biotech industry

Education

biotechnology india

biotechnology industry

biotech capital of india

indian biotechnology

biotech companiesoperate

national biotechnology

crore biotech revenue

bioindustrial sector